Elanda Pharmasp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-08-10
Share capital
650 000,00 PLN
Activity description

Elanda Pharma is a Polish brand based in Rozprza that has developed and manufactured medicines, cosmetics, dietary supplements, veterinary products and medical devices for domestic and international markets for over 30 years. The company provides contract manufacturing services covering formulation development, manufacturing and packaging technology, documentation, quality testing, technology transfer, stability studies and process validation. It specializes in liquid and semi-liquid product forms, including syrups, drops, suspensions, creams, ointments, gels and emulsions, in accordance with GMP, ISO 13485 and HACCP standards.

Registered address
ul. Sportowa 9, 97-340 Rozprza, Poland
Website
elanda.plWebsite active
Phone
Electronic delivery address
AE:PL-82152-17936-FDDHW-30

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 2.73mMedianUSD 782.27kAverageUSD 24.03m
Net profit
This companyUSD 65.21kMedianUSD 7.91kAverageUSD 2.59m
Operating costs
This companyUSD 2.55mMedianUSD 723.93kAverageUSD 19.92m
Assets
This companyUSD 1.77mMedianUSD 800.34kAverageUSD 29.11m

Bank accounts

Registered as a VAT taxpayer on 1993-09-07. Active

  • mBank
    06 1140 2062 0000 5747 2600 1012
  • mBank
    14 1140 1010 0000 5747 2600 1005
  • mBank
    25 1140 1010 0000 5747 2600 1001

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$13,617
Buildings and premises
$453.9K

MSiG notices

Publication dateEvent
Aug 23, 2018Transformation registered

Public aid

11 public aid cases recorded, with a total value of $620,560.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
Regional investment aid
–

European Funds

ProjectEU co-financing
Automatyzacja procesów produkcji w firmie ELANDA PHARMA.
$476.2K

Tenders

No recorded participation in tenders.

Trademarks

Elanda Pharma holds 4 active trademarks registered with the Polish Patent Office. The first mark was filed in 2018.

MarkProtected until
LAXANTIA(word)Sep 10, 2028
ELANDA PHARMA(word)Sep 10, 2028
STOMATOSOL(word)Jul 17, 2028
PARADENTOSOL(word)Jul 17, 2028

Regulatory authorisations

AuthorityTypeStatus
Waste generation Active

Authorized Representatives

Lesław Dyrda – Attorney-in-fact (joint)
Karol Korda – President of the Management Board

Manner of representation

Each member of the management board is authorised to represent the company independently.

Ownership

OwnerSharesShare valueStake
Verco S.A.
13,000$175,580.77100%

Beneficial owners

Person

Change history

DateEvent
2026-08-17PKD change
2024-11-04Share capital change
2024-03-14Share capital change
2019-05-21Share capital change
2018-10-24Address change

FAQ

Last updated: 2026-10-07